Our findings demonstrated inactivation of MT1-MMP in ARF6 and NEDD9 knockdown endometrial cancer cells compared to control siRNA transfected cells, implying that ARF6 and NEDD9 are upstream of MT1-MMP and modulators of MT1-MMP. The gene discussed is ARF6; the disease is endometrial cancer.